BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 30990148)

  • 1. [Impact of Diabetes Mellitus and blood glucose levels on the results of treatment of patients with ST-elevation myocardial infarction undergoing percutaneous coronary interventions].
    Bessonov IS; Kuznetsov VA; Ziryanov IP; Sapozhnikov SS; Potolinskaya YV
    Kardiologiia; 2019 Apr; 59(3S):16-22. PubMed ID: 30990148
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Impact of hyperglycemia on the results of percutaneous coronary interventions in patients with acute ST-segment elevation myocardial infarction].
    Bessonov IS; Kuznetsov VA; Potolinskaya YV; Zyrianov IP; Sapozhnikov SS
    Ter Arkh; 2017; 89(9):25-29. PubMed ID: 29039827
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Association of Strategy of Direct Stenting of Infarct-Related Artery with Reduction of Mortality in Woman with ST-Elevation Myocardial Infarction].
    Bessonov IS; Kuznetsov VA; Ziryanov IP; Sapozhnikov SS
    Kardiologiia; 2019 Apr; 59(4):5-11. PubMed ID: 31002033
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of Total Ischemic Time on Clinical Outcomes in Patients with ST-Segment Elevation Myocardial Infarction.
    Bessonov IS; Kuznetsov VA; Gorbatenko EA; Dyakova AO; Sapozhnikov SS
    Kardiologiia; 2021 Mar; 61(2):40-46. PubMed ID: 33734047
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma apelin-12 levels may predict in-hospital major adverse cardiac events in ST-elevation myocardial infarction and the relationship between apelin-12 and the neutrophil/lymphocyte ratio in patients undergoing primary coronary intervention.
    Topuz M; Oz F; Akkus O; Sen O; Topuz AN; Bulut A; Ozbicer S; Okar S; Koc M; Gur M
    Perfusion; 2017 Apr; 32(3):206-213. PubMed ID: 27770057
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Comparison of Direct Stenting Versus Stending After Pre-Dilation in ST-Elevation Myocardial Infarction].
    Kuznetsov VA; Bessonov IS; Zyrianov IP; Zyrianova TI; Sapozhnikov SS; Potolinskaya YV
    Kardiologiia; 2017 Nov; 57(11):5-10. PubMed ID: 29276911
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Percutaneous Coronary Interventions in Patients With ST-Elevation Myocardial Infarction: 10-Years Follow-up].
    Bessonov IS; Kuznetsov VA; Dyakova AO; Gorbatenko EA; Evlampieva LG; Kicherova OA; Reikhert LI; Nyamtsu AM; Gultyaeva EP
    Kardiologiia; 2020 Jul; 60(6):982. PubMed ID: 32720619
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predictive value of admission red cell distribution width-platelet ratio for no-reflow phenomenon in acute ST segment elevation myocardial infarction undergoing primary percutaneous coronary intervention.
    Celık T; Balta S; Demır M; Yıldırım AO; Kaya MG; Ozturk C; Demırkol S; Unlu M; Kılıc S; Aydın İ; Iyısoy A
    Cardiol J; 2016; 23(1):84-92. PubMed ID: 26503078
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Correlation of serum uric acid levels with coronary flow in patients with ST-segment elevation myocardial infarction undergoing primary coronary intervention].
    Wang JW; Chen YD; Wang CH; Zhu XL
    Zhonghua Yi Xue Za Zhi; 2012 Nov; 92(44):3100-3. PubMed ID: 23328417
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of the "door-to-balloon" time on the results of treatment of patients with ST-segment elevation myocardial infarction, depending on the duration of the pre-hospital delay.
    Bessonov IS; Sapozhnikov SS; Shadrin AA; Kashtanov MG; Popov SV
    Kardiologiia; 2023 Jun; 63(6):28-36. PubMed ID: 37470731
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Angiotensin-converting enzyme inhibitors versus angiotensin II receptor blockers in acute ST-segment elevation myocardial infarction patients with diabetes mellitus undergoing percutaneous coronary intervention.
    Choi SY; Choi BG; Rha SW; Byun JK; Shim MS; Li H; Mashaly A; Choi CU; Park CG; Seo HS; Oh DJ; Jeong MH;
    Int J Cardiol; 2017 Dec; 249():48-54. PubMed ID: 28867244
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Correlations between clinical and laboratory findings and prognostically unfavorable CMR-based characteristics of acute ST-elevation myocardial infarction.
    Terenicheva MA; Shakhnovich RM; Stukalova OV; Pevzner DV; Arutyunyan GK; Demchenkova AY; Merkulova IN; Ternovoy SK
    Kardiologiia; 2021 Feb; 61(1):44-51. PubMed ID: 33734055
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neutrophil/Lymphocyte Ratio as a Predictor of In-Hospital Major Adverse Cardiac Events, New-Onset Atrial Fibrillation, and No-Reflow Phenomenon in Patients with ST Elevation Myocardial Infarction.
    Wagdy S; Sobhy M; Loutfi M
    Clin Med Insights Cardiol; 2016; 10():19-22. PubMed ID: 26884687
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of Stent Length on Periprocedural Outcomes After Primary Percutaneous Coronary Intervention in Patients with ST Segment Elevation Myocardial Infarction.
    Chen Y; Gao YF; Wang YF; Wang CJ; Du Y; Ding YH
    Clin Interv Aging; 2022; 17():1687-1695. PubMed ID: 36467316
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Non-O blood groups can be a prognostic marker of in-hospital and long-term major adverse cardiovascular events in patients with ST elevation myocardial infarction undergoing primary percutaneous coronary intervention.
    Cetin MS; Ozcan Cetin EH; Aras D; Topaloglu S; Temizhan A; Kisacik HL; Aydogdu S
    Thromb Res; 2015 Sep; 136(3):599-605. PubMed ID: 26251078
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Day-to-day fasting plasma glucose variability on the short-term prognosis of ST-segment elevation myocardial infarction: A retrospective cohort study.
    Yi M; Cao Q; Tang WH; Liu Q; Ke X
    Clin Cardiol; 2022 Dec; 45(12):1246-1254. PubMed ID: 36069119
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Does glucose level at hospital discharge predict one-year mortality in patients with diabetes mellitus treated with percutaneous coronary intervention for ST-segment elevation myocardial infarction?
    Gasior M; Pres D; Stasik-Pres G; Lech P; Gierlotka M; Lekston A; Hawranek M; Tajstra M; Kalarus Z; Poloński L
    Kardiol Pol; 2008 Jan; 66(1):1-8; discussion 9-11. PubMed ID: 18266182
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Does Serum Bilirubin level on admission predict TIMI flow grade and in-hospital MACE in patients with STEMI undergoing primary PCI.
    Celik T; Kaya MG; Akpek M; Yarlioglues M; Sarli B; Topsakal R; Gibson CM
    Angiology; 2014 Mar; 65(3):198-204. PubMed ID: 23378197
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Meta-analysis of randomized controlled trials comparing percutaneous coronary intervention with aspiration thrombectomy Vs. Conventional percutaneous coronary intervention during ST-segment elevation myocardial infarction.
    Dominguez AC; Bittl JA; El-Hayek G; Contreras E; Tamis-Holland JE
    Catheter Cardiovasc Interv; 2016 Jun; 87(7):1203-10. PubMed ID: 26699698
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Primary percutaneous interventions into the coronary arteries in patients with diabetes mellitus].
    Bessonov IS; Kuznetsov VA; Zyryanov IP; Sapozhnikov SS; Musikhina NA; Rozhkov AG
    Ter Arkh; 2016; 88(8):35-39. PubMed ID: 27636925
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.